Recent bipartisan legislation aims to enhance the federal biotechnology workforce by involving the Office of Personnel Management (OPM) in a comprehensive assessment of current and future needs.
Introduced by Representatives Ro Khanna and Rich McCormick, the Federal Biotechnology Workforce Assessment Act mandates OPM to collaborate with various agency heads to define the federal biotech workforce and evaluate its requirements. This initiative is pivotal for maintaining the U.S. competitive edge in biotechnology, particularly against China. Khanna emphasized the importance of investing in this workforce to uphold America’s leadership in scientific innovation.
The primary objective of the OPM assessment is to ascertain the total biotech positions needed across key federal departments, including Agriculture, Defense, and Health and Human Services. The legislation outlines the necessity for OPM to detail how these positions align with federal goals and to identify any barriers to workforce development. Additionally, it explores the potential for cross-agency talent sharing and training initiatives to fill existing gaps.
The proposed legislation also recognizes the role of the private sector in supporting federal biotech needs, suggesting the establishment of a pool of external experts and public-private talent exchanges. Complementing this, McCormick’s Biotechnology Workforce Alignment Act aims to enhance alignment between federal research investments and biotech workforce pathways, further solidifying a collaborative approach to workforce development in this critical sector.
This legislative push reflects ongoing efforts to bolster the U.S. position in biotechnology and AI, addressing both immediate workforce needs and long-term educational initiatives to cultivate talent in the industry.